Bespoke Extracts (BSPK) Common Equity (2011 - 2025)

Bespoke Extracts has disclosed Common Equity across 15 years of filings, most recently posting -$2.6 million for Q3 2025.

• Common Equity for Q3 2025 came in at -$2.6 million, down 11.42% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.6 million (down 11.42% YoY), and the FY2024 annual result was -$2.1 million, down 21.3% from the prior year.
• Common Equity came in at -$2.6 million for Q3 2025 at Bespoke Extracts, down from -$2.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $2.0 million in Q1 2022 to a low of -$2.6 million in Q3 2025.
• The 5-year median for Common Equity is -$1.3 million (2023), against an average of -$930336.6.
• Across the five-year window, Common Equity soared 111.92% in 2021 and tumbled 200.26% in 2023, its largest moves.
• Bespoke Extracts' Common Equity stood at -$79724.0 in 2021, then tumbled by 743.03% to -$672096.0 in 2022, then slumped by 156.59% to -$1.7 million in 2023, then decreased by 21.3% to -$2.1 million in 2024, then decreased by 24.07% to -$2.6 million in 2025.
• The last three Common Equity figures came in at -$2.6 million (Q3 2025), -$2.5 million (Q2 2025), and -$2.3 million (Q1 2025), per Business Quant data.